Suppr超能文献

从大鼠腹腔渗出液中纯化并对一种抑制磷脂酶A2活性的37 kDa蛋白质进行部分序列分析。

Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates.

作者信息

Pepinsky R B, Sinclair L K, Browning J L, Mattaliano R J, Smart J E, Chow E P, Falbel T, Ribolini A, Garwin J L, Wallner B P

出版信息

J Biol Chem. 1986 Mar 25;261(9):4239-46.

PMID:3081518
Abstract

We have purified from rat peritoneal exudates a 37-kDa protein that inhibits phospholipase A2 activity. It is the predominant phospholipase inhibitor protein in these preparations and also is detected in a wide variety of cell lines. Levels of expression range from 0 to 0.5% of total protein. In the peritoneal preparations, the inhibitor is partially proteolyzed into a series of lower mass forms, including species at 30, 24, and 15 kDa. These fragments all are immunoreactive with an antibody raised against the 37-kDa protein. The rat protein also is immunoreactive with an antibody developed against a 6-kDa phospholipase inhibitor protein from snake venom. The primary structure of more than half of the rat inhibitor has been deduced by protein microsequence analysis. These sequences are closely related to sequences from its human analogue, which we recently cloned and expressed (Wallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., and Pepinsky, R. B. (1986) Nature, in press), and thus we infer that the inhibitor is highly conserved evolutionarily. Properties of the molecule suggest that it is a member of a family of steroid-induced anti-inflammatory proteins collectively referred to as lipocortin.

摘要

我们已从大鼠腹腔渗出液中纯化出一种抑制磷脂酶A2活性的37 kDa蛋白。它是这些制剂中主要的磷脂酶抑制蛋白,在多种细胞系中也可检测到。其表达水平占总蛋白的0%至0.5%。在腹腔制剂中,该抑制剂被部分蛋白酶解为一系列分子量较低的形式,包括30 kDa、24 kDa和15 kDa的蛋白。这些片段都能与针对37 kDa蛋白产生的抗体发生免疫反应。大鼠蛋白也能与针对蛇毒中一种6 kDa磷脂酶抑制蛋白产生的抗体发生免疫反应。通过蛋白质微量序列分析已推断出大鼠抑制剂一半以上的一级结构。这些序列与其人类类似物的序列密切相关,我们最近已克隆并表达了该人类类似物(Wallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., and Pepinsky, R. B. (1986) Nature, in press),因此我们推断该抑制剂在进化上高度保守。该分子的特性表明它是类固醇诱导的抗炎蛋白家族的一员,统称为脂皮质素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验